Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:28 (7 July), doi:10.1136/bmj.39196.740995.BE (published 21 May 2007)
Guglielmo Ronco, responsible, Cervical Screening Evaluation Unit1, Jack Cuzick, director12, Paola Pierotti, senior biologist8, Maria Paola Cariaggi, director, Unit of Cytopathology3, Paolo Dalla Palma, director, Unit of Pathology4, Carlo Naldoni, coordinator regional cancer screening programmes7, Bruno Ghiringhello, director, Unit of Pathology2, Paolo Giorgi-Rossi, responsible10, Daria Minucci, director6, Franca Parisio, senior biologist2, Ada Pojer, senior biologist4, Maria Luisa Schiboni, senior biologist11, Catia Sintoni, senior biologist9, Manuel Zorzi, epidemiologist5, Nereo Segnan, director1, Massimo Confortini, director, Unit of Analytic and Biomolecular Cytology3
1 Unit of Cancer Epidemiology, Centre for Cancer Prevention, Via S Francesco da Paola 31 10123 Turin, Italy, 2 S Anna Hospital, Turin, Italy , 3 Scientific Institute for Cancer Prevention of Tuscany Region, Florence, Italy, 4 S Chiara Hospital, Trento, Italy, 5 Venetian Tumour Registry, Istituto Oncologico Veneto, Padua, Italy , 6 Unit of Obstetrics and Gynaecology, University Hospital, Padua, Italy, 7 Emilia-Romagna Region, Bologna, Italy , 8 Maggiore Hospital, AUSL Bologna, Italy , 9 S Maria delle Croci Hospital, Ravenna, Italy , 10 Health Technologies Unit, Agency for Public Health Lazio Region, Rome, Italy , 11 S Giovanni Hospital, Rome, Italy , 12 Cancer Research UK Clinical Centre, Epidemiology, Mathematics and Statistics, Queen Mary's School of Medicine and Dentistry, London
Correspondence to: G Ronco guglielmo.ronco{at}cpo.it
Design Randomised controlled trial.
Setting Nine screening programmes in Italy.
Participants Women aged 25-60 attending for a new screening round: 22 466 were assigned to the conventional arm and 22 708 were assigned to the experimental arm.
Interventions Conventional cytology compared with liquid based cytology and testing for human papillomavirus.
Main outcome measure Relative sensitivity for cervical intraepithelial neoplasia of grade 2 or more at blindly reviewed histology, with atypical cells of undetermined significance or more severe cytology considered a positive result.
Results In an intention to screen analysis liquid based cytology showed no significant increase in sensitivity for cervical intraepithelial neoplasia of grade 2 or more (relative sensitivity 1.17, 95% confidence interval 0.87 to 1.56) whereas the positive predictive value was reduced (relative positive predictive value v conventional cytology 0.58, 0.44 to 0.77). Liquid based cytology detected more lesions of grade 1 or more (relative sensitivity 1.68, 1.40 to 2.02), with a larger increase among women aged 25-34 (P for heterogeneity 0.0006), but did not detect more lesions of grade 3 or more (relative sensitivity 0.84, 0.56 to 1.25). Results were similar when only low grade intraepithelial lesions or more severe cytology were considered a positive result. No evidence was found of heterogeneity between centres or of improvement with increasing time from start of the study. The relative frequency of women with at least one unsatisfactory result was lower with liquid based cytology (0.62, 0.56 to 0.69).
Conclusion Liquid based cytology showed no statistically significant difference in sensitivity to conventional cytology for detection of cervical intraepithelial neoplasia of grade 2 or more. More positive results were found, however, leading to a lower positive predictive value. A large reduction in unsatisfactory smears was evident.
Trial registration Current Controlled Trials ISRCTN81678807 [controlled-trials.com] .
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.